Clinical Trials Directory

Trials / Completed

CompletedNCT00707603

Chronic Hepatitis C and Insulin Resistance

Understanding the Relationship Between Insulin Resistance and Chronic Hepatitis C Infection

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Garvan Institute of Medical Research · Academic / Other
Sex
Male
Age
25 Years – 55 Years
Healthy volunteers
Accepted

Summary

Chronic hepatitis C (CHC) is among the commonest chronic infectious disease in Australia with \>200,000 exposed persons. Amongst non-infectious chronic conditions- Type 2 diabetes, obesity and heart disease are extremely common. This study will examine the relationship between insulin resistance, fat deposition in the liver, muscle and abdomen, and liver injury due to CHC

Conditions

Timeline

Start date
2006-05-01
Primary completion
2008-12-01
Completion
2008-12-01
First posted
2008-07-01
Last updated
2015-07-14

Locations

2 sites across 1 country: Australia

Source: ClinicalTrials.gov record NCT00707603. Inclusion in this directory is not an endorsement.

Chronic Hepatitis C and Insulin Resistance (NCT00707603) · Clinical Trials Directory